1. Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products.
- Author
-
Huang FP, Xi G, Keep RF, Hua Y, Nemoianu A, and Hoff JT
- Subjects
- Animals, Bilirubin adverse effects, Bilirubin physiology, Brain drug effects, Brain physiopathology, Brain Edema chemically induced, Deferoxamine pharmacology, Disease Models, Animal, Heme Oxygenase (Decyclizing) adverse effects, Heme Oxygenase (Decyclizing) antagonists & inhibitors, Heme Oxygenase (Decyclizing) physiology, Heme Oxygenase-1, Hemin adverse effects, Hemin physiology, Hemoglobins drug effects, Male, Metalloporphyrins pharmacology, Protoporphyrins pharmacology, Rats, Rats, Sprague-Dawley, Stereotaxic Techniques, Up-Regulation physiology, Brain Edema etiology, Brain Edema physiopathology, Cerebral Hemorrhage complications, Cerebral Hemorrhage physiopathology, Fibrin Fibrinogen Degradation Products physiology, Hemoglobins adverse effects, Hemoglobins physiology
- Abstract
Object: The mechanisms involved in brain edema formation following intracerebral hemorrhage (ICH) have not been fully elucidated. The authors have found that red blood cell lysis plays an important role in edema development after ICH. In the present study, they sought to determine whether degradation products of hemoglobin cause brain edema., Methods: Hemoglobin, hemin, bilirubin, or FeCl2 were infused with stereotactic guidance into the right basal ganglia of Sprague-Dawley rats. The animals were killed 24 hours later to determine brain water and ion contents. Western blot analysis and immunohistochemistry were applied for heme oxygenase-1 (HO-1) measurement. The effects of an HO inhibitor, tin-protoporphyrin (SnPP), and the iron chelator deferoxamine, on hemoglobin-induced brain edema were also examined. Intracerebral infusion of hemoglobin, hemin, bilirubin, or FeCl2 caused an increase in brain water content at 24 hours. The HO-1 was upregulated after hemoglobin infusion and HO inhibition by SnPP-attenuated hemoglobin-induced edema. Brain edema induced by hemoglobin was also attenuated by the intraperitoneal injection of 500 mg/kg deferoxamine., Conclusions: Hemoglobin causes brain edema, at least in part, through its degradation products. Limiting hemoglobin degradation coupled with the use of iron chelators may be a novel therapeutic approach to limit brain edema after ICH.
- Published
- 2002
- Full Text
- View/download PDF